MERS-CoV Pseudovirus (ORF1 a/b, ORF4 b, N) (CAT#: PSV-Wyb004)

• Product Overview
• MERS-CoV Pseudovirus uses a retroviral vector loaded with the partial sequence of the ORF1 a/b and ORF4 b gene of MERS-CoV virus, and the entire sequence of the coding region of the N gene. This product is prepared in 293T cells and is wrapped around the outer membrane of the retrovirus. This product is used for the ability verification of MERS-CoV virus nucleic acid detection reagents and the performance verification of extraction kits. It can also be used to carry out MERS-CoV virus nucleic acid detection laboratories for test ability verification and laboratory quality control.

• Product Type
• Pseudovirus

• Target
• MERS-CoV

• Contents
• Contains partial sequence of the ORF1 a/b and ORF4 b gene of MERS-CoV virus, and the entire sequence of the coding region of the N gene.

• Backbone
• Retroviral vector

• Reporter Gene
• Luciferase

• Variant
• Wuhan-Hu-1

• Titer
• 10⁸ virus copies/mL

• Applications
• Used for the ability verification of MERS-CoV virus nucleic acid detection reagents and the performance verification of extraction kits. It can also be used to carry out MERS-CoV virus nucleic acid detection laboratories for test ability verification and laboratory quality control.

• Storage
• Store at -80°C.

• Introduction
• The MERS (Middle East Respiratory Syndrome) virus is a new type of coronavirus, and most MERS virus infections occur in Saudi Arabia. MERS-CoV was first discovered in Saudi Arabia in September 2012. It is similar to the SARS virus in its clinical symptoms. It was also named SARS-like virus in the early days. It is the sixth known human coronavirus. MERS-CoV is often confused with SARS, but in fact both viruses belong to the coronavirus, but they are genetically distinct and they use different receptors when infecting humans.

• Alternative Names
• Middle East Respiratory Syndrome Virus; MERS-CoV; Nidovirales; Coronaviridae; Coronavirus; MERS coronavirus